Form4insider filings, from the source

SEC Form 4 · accession 0000899243-17-013908

Global Blood Therapeutics, Inc. · GBT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Mark J Levin
10% Owner
Kevin P Starr
10% Owner
Period of report
May 17, 2017
Accepted (ET)
May 19, 2017 · 4:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001629137

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Apr 11, 2017G50,000$0.00D165,704D
Common StockF1Apr 18, 2017G1,708$0.00D163,996D
Common StockF2,F3May 17, 2017J1,000,000—D3,475,191D
Common StockF4,F5holding———193,677D
Common StockF6,F5holding———181,721D
Common StockF7,F5holding———259,454D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses